Strategies for Advancing Molecular Glue Drug Discovery

DATE
September 9, 2025
TIME
8:00 a.m. PDT, 11:00 a.m. EDT, 16:00 BST, 17:00 CEST

Overview

Molecular glues act as "molecular adhesives”, facilitating or stabilizing interactions between proteins that might not otherwise bind strongly or at all. Molecular glues show great potential for treating diseases such as cancer and infectious, inflammatory, and neurodegenerative diseases. 

A key application of molecular glues is in targeted protein degradation, where they facilitate the proximity of a target protein to an E3 ubiquitin ligase, resulting in the protein's degradation. New modalities, such as molecular glues, require robust screening strategies to identify and develop the most promising candidates efficiently.

This expert-led presentation will introduce WuXi Biology’s end-to-end molecular glue discovery platform. Using advanced screening technologies, assays, and cutting-edge animal models, our platform allows for extensive in vitro and in vivo characterization of these unique molecules. This webinar offers an in-depth perspective on strategies crucial for accelerating research focused on the development of molecular glue-based therapeutics.

Key Learning Objectives:
  • Explore how molecular glues drive targeted protein degradation and why effective screening is key to discovering viable candidates;
  • Learn advanced screening and assay technologies tailored for identifying and characterizing molecular glue candidates;
  • Get a front-row look at WuXi Biology’s end-to-end discovery platform, from screening to in vivo validation.
Who Should Attend:
  • Researchers working on molecular glue drug discovery
  • Researchers interested in strategies and approaches for lead optimization of molecular glues
  • Research teams focused on bifunctional molecules and new modalities for “undruggable” targets


Brought to you by:
WuXi AppTec logo

Speakers

Jian Xiang, Ph.D.
Director, Site Head of WuXi Biology In Vivo Pharmacology Unit Suzhou branch,
WuXi AppTec
Peichuan Zhang, Ph.D.
Director, WuXi Biology,
WuXi AppTec
Lulu Zhang, Ph.D.
Associate Director, WuXi Biology,
WuXi AppTec
Kelly McSweeney
Contributing Editor,
C&EN Media Group

Registration






e.g., target engagement, degradation confirmation, in vivo translation...
*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society and its sponsor via email. You understand that you can withdraw your consent at any time. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

© 2025 American Chemical Society, 1155 16th St NW, Washington, DC 20036, USA. View our Privacy Policy